A federal appeals court recently examined a legal challenge that threatens to eliminate access to medication abortion nationwide, even in states where abortion remains legally protected. The case centers on arguments from Louisiana, the FDA, and drug manufacturers over whether the agency’s approval of abortion pills can be overturned. Judges questioned whether the FDA’s authority over these medications could be undermined, raising concerns about reproductive rights across the country. The outcome could reshape how abortion care is delivered, regardless of state laws.
A federal appeals court Wednesday heard arguments in a case that could eventually wipe out access to medication abortion, even in blue states that protect abortion. A three-judge panel of the 5th U.S. Circuit Court of Appeals peppered questions on attorneys for Louisiana, the Food and Drug Administration (FDA) and two manufacturers and distributors of...
